Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus
By interweaving nucleic acid scientists with clinicians dedicated to finding new cures, our goal is to create a new paradigm for organizing molecular research that enables the rapid application of new biological discoveries to solutions for unmet challenges in human health. Our current focus is on Huntington’s disease, alpha-1 antitrypsin deficiency, viral infections, preeclampsia, cancer, and more.
Listen to Phillip Zamore discuss Gene Silencing through RNAi with 'Finding a Genius' Podcaster Richard Jacobs.
RNA Therapeutics Buzz
Dr. Craig Mello was featured on WBZ Channel 4 Boston - Local Nobel Prize Winner Hopes COVID Vaccine RNA Technology Can Fight Other Diseases
New publication from the Zamore Lab - Defining the functions of PIWI-interacting RNAs
ScienceLIVE brings virtual labs to area middle school students
Welcome to our newest faculty members, Wenwen Fang and Li Li!
More RTI news...
For decades, scientists at the University of Massachusetts Medical School have been pioneers in RNA biology and leading innovators in the development of information-based therapeutics: cutting-edge therapeutic tools that leverage our advanced understanding of the human genome in ways that are revolutionizing how we treat disease. With your support, we are poised to unleash their power, and change the world for the better.
